Tag: said-it-had
-
Warplanes knock out Aleppo hospital as Russian-backed assault intensifies
By Ellen Francis and Tom Perry BEIRUT (Reuters) – Russian or Syrian warplanes knocked a major Aleppo hospital out of service on Wednesday, hospital workers said, and ground forces intensified an assault on the city's besieged rebel sector, in a battle that has become a potentially decisive turning point in the civil war. The World…
-
Thais probe babies with microcephaly for Zika link
Thai doctors are running tests to see whether Zika was the cause of microcephaly in two babies whose mothers are infected with the mosquito-borne virus, a health official said Wednesday. If the remaining pair are found to be linked, they could be the first case of Zika-related microcephaly in Southeast Asia, according to the World…
-
Bayer announces $62 billion cash offer for Monsanto
German drugs and chemicals group Bayer AG said it had made an offer to buy U.S. seeds company Monsanto Co for $122 per share in cash, or a total value of $62 billion including debt, to create the world's biggest agricultural supplier. Bayer said on Monday that the proposal made to Monsanto's management represented a…
-
Insurer AXA to sell 1.8 billion euros of tobacco assets
French insurer AXA plans to stop investing in the tobacco industry, citing the impact of smoking on public health, and said it plans to sell its 1.8 billion euros ($2.02 billion) of assets in the sector. AXA said it would divest its 200 million euros of equity holdings in tobacco companies immediately. It also plans…
-
China suspends Ali Health-run online drug monitoring platform
China’s food and drugs regulatory body said it had suspended its electronic drug monitoring system, a platform operated by Alibaba Health Information Technology Ltd, while it drafts amendments to regulations monitoring pharmaceutical sales. The China Food and Drug Administration (CFDA) said it will seek comments until March 23 on changes to the way pharmaceutical products…
-
Sanofi submits new diabetes drug application to U.S. regulator
French drugmaker Sanofi said on Wednesday it had submitted an application to the U.S. Food and Drug Administration (FDA) for a single daily insulin injection to treat adults with type 2 diabetes. Sanofi said it had requested a six-month review of its new drug application by the FDA, rather than the standard 10 months. “A…
-
Sanofi submits new diabetes drug application to U.S. regulator
French drugmaker Sanofi said on Wednesday it had submitted an application to the U.S. Food and Drug Administration (FDA) for a single daily insulin injection to treat adults with type 2 diabetes. Sanofi said it had requested a six-month review of its new drug application by the FDA, rather than the standard 10 months. “A…